Toralgen

About:

Toralgen is a biopharmaceutical firm that provides the development and commercialization of human therapeutics.

Top Investors: VisionTech Partners, Elevate Ventures, Solyco Capital

Description:

Toralgen is a is a preclinical stage biopharmaceutical company that specializes in the development and commercialization of human therapeutics. They eliminates the challenges of oral delivery in one simple-to-fabricate nanopill. These nanopills also localize the delivery of drug agents and improve the efficacy and safety of therapies.

Total Funding Amount:

$10.2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Indianapolis, Indiana, United States

Founded Date:

2017-01-01

Contact Email:

dnmaem(AT)gmail.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2020-12-14

IPO Status:

Private

Industries: